Susquehanna International Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$352K Buy
+20,300
New +$384K ﹤0.01% 10513
2025
Q4
Sell
-18,400
Closed -$268K 12436
2025
Q3
$268K Sell
18,400
-13,500
-42% -$192K ﹤0.01% 10380
2025
Q2
$623K Buy
31,900
+17,800
+126% +$316K ﹤0.01% 8658
2025
Q1
$250K Buy
14,100
+1,600
+13% +$34.5K ﹤0.01% 10472
2024
Q4
$268K Sell
12,500
-38,000
-75% -$924K ﹤0.01% 10077
2024
Q3
$1.58M Buy
50,500
+13,700
+37% +$341K ﹤0.01% 5789
2024
Q2
$572K Sell
36,800
-39,100
-52% -$473K ﹤0.01% 7937
2024
Q1
$804K Buy
75,900
+58,000
+324% +$580K ﹤0.01% 7398
2023
Q4
$215K Buy
+17,900
New +$147K ﹤0.01% 10532
2023
Q3
Sell
-10,200
Closed -$86.7K 12073
2023
Q2
$86.7K Sell
10,200
-14,400
-59% -$120K ﹤0.01% 11054
2023
Q1
$225K Buy
+24,600
New +$315K ﹤0.01% 10343
2022
Q4
Sell
-14,000
Closed -$238K 12502
2022
Q3
$238K Sell
14,000
-8,400
-38% -$180K ﹤0.01% 10402
2022
Q2
$481K Sell
22,400
-25,900
-54% -$718K ﹤0.01% 8355
2022
Q1
$1.79M Buy
48,300
+7,600
+19% +$296K ﹤0.01% 5728
2021
Q4
$1.85M Sell
40,700
-1,100
-3% -$57.4K ﹤0.01% 5695
2021
Q3
$2.65M Sell
41,800
-193,800
-82% -$14.8M ﹤0.01% 5224
2021
Q2
$21.6M Buy
235,600
+139,000
+144% +$11M ﹤0.01% 1933
2021
Q1
$6.58M Buy
96,600
+26,900
+39% +$2.09M ﹤0.01% 3427
2020
Q4
$5.05M Sell
69,700
-59,800
-46% -$3.46M ﹤0.01% 3402
2020
Q3
$4.91M Buy
129,500
+27,600
+27% +$932K ﹤0.01% 3072
2020
Q2
$3.61M Buy
101,900
+42,500
+72% +$1.21M ﹤0.01% 3495
2020
Q1
$1.3M Buy
59,400
+28,300
+91% +$634K ﹤0.01% 4784
2019
Q4
$671K Sell
31,100
-17,700
-36% -$406K ﹤0.01% 6346
2019
Q3
$1.1M Sell
48,800
-115,200
-70% -$3.19M ﹤0.01% 5492
2019
Q2
$5.9M Sell
164,000
-20,500
-11% -$656K ﹤0.01% 2495
2019
Q1
$5.82M Buy
184,500
+138,200
+298% +$4.03M ﹤0.01% 2293
2018
Q4
$1.16M Buy
46,300
+10,000
+28% +$257K ﹤0.01% 4396
2018
Q3
$1.05M Buy
+36,300
New +$679K ﹤0.01% 5132

Other funds holding CDNA

Susquehanna International Group's CDNA Position: Q1 2026 in Review

Susquehanna International Group increased its CareDx (CDNA) stake by 6.5% in Q1 2026, buying an estimated $58.7K and bringing the position to 50,646 shares worth $879K. The position accounts for ﹤0.01% of the portfolio, ranked #8221.

Susquehanna International Group first reported a position in CDNA in Q1 2018 and has held it in 29 quarters since. The position peaked at $4.52M in Q4 2020. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Susquehanna International Group held 50,646 shares of CareDx worth $879K as of Q1 2026.
  • Susquehanna International Group bought 3,101 CareDx shares in Q1 2026, an estimated $58.7K.
  • CareDx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8221 holding.
  • Susquehanna International Group first reported a position in CareDx in Q1 2018 and has held it in 29 quarters since.
  • Susquehanna International Group's CareDx position peaked at $4.52M in Q4 2020.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.